NotreDame Intermedica Saude S.A

São Paulo 01229-010

0 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, Cardiovascular Diseases, Chronic Kidney Disease, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer — Stopped early